Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines
about
Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxideCharacterization of C-Alkyl Amidines as Bioavailable Covalent Reversible Inhibitors of Human DDAH-1Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and DevelopmentLow Homoarginine Levels in the Prognosis of Patients With Acute Chest PainModeling binding kinetics at the Q(A) site in bacterial reaction centers.Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.Homoarginine supplementation improves blood glucose in diet-induced obese mice.High urinary homoarginine excretion is associated with low rates of all-cause mortality and graft failure in renal transplant recipients.Role of substrate functional groups in binding to nitric oxide synthase.Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free L-arginine in humans.Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine.Plasma Homoarginine Concentrations According to Use of Hormonal Contraception
P2860
Q24321779-5FB6D92C-8C58-447F-9F9B-FB3572E7AB35Q27665385-6463FE1A-9D6C-4743-BB68-4E57ECDC31F2Q28070134-2CB61197-C567-4B9B-A77B-9F9CAFC6B7ECQ36877207-5A0B2743-CF26-4874-94EB-857F2B88E3A9Q37305554-75565C55-C768-45D3-B176-0DDDE775F162Q37372675-793495B7-947E-4DB3-A899-78EDAD86DEE9Q40832621-2FA42CDB-D949-4C6C-864D-5A5BE93BF35BQ41612939-ED8E8BA3-E0FA-4B4E-AA4B-A04D2EFD9D4CQ42207508-7098CD1B-D085-42D3-8201-DDE3BB532361Q48137886-73479484-62CA-401F-845E-E5D9DD3062C3Q50584390-81595014-7481-4FAF-8DFA-AE91CD07ABE7Q52854692-BD3DC5C2-5C86-4962-80BE-A999C221B4BAQ58778478-40314F92-83E2-4BFE-8EC4-FD6FBF0A7A27
P2860
Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@ast
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@en
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@nl
type
label
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@ast
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@en
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@nl
prefLabel
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@ast
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@en
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@nl
P2093
P2860
P3181
P356
P1476
Structural characterization an ...... d N5-(iminoalkenyl)-ornithines
@en
P2093
Huiying Li
Lynn E Bretscher
Owen W Griffith
Thomas L Poulos
P2860
P304
P3181
P356
10.1074/JBC.M306787200
P407
P577
2003-11-21T00:00:00Z